澳大新語 • 2024 UMAGAZINE 30 10 封面專題 • COVER STORY and South Korea. In March 2024, it co-founded the Guangdong-Hong Kong-Macao University Alliance for Acupuncture with the Chinese University of Hong Kong and Guangzhou University of Chinese Medicine. In recent years, the laboratory has also co-hosted seminars and postgraduate forums with institutions including the University of Oxford, Tsinghua University, Hubei University of Chinese Medicine, Korea University, the University of Tokyo, and the University of Sydney. Furthermore, scholars from SKL-QRCM serve as editors for several academic journals, including Chinese Medicine. Published by Springer Nature, this international journal enjoys a strong academic reputation. Providing Pharmaceutical Education To develop professionals in medicine and pharmaceutics, SKL-QRCM has offered master’s programmes in Chinese medicine and pharmaceutical administration since 2002, as well as a PhD programme in biomedical sciences since 2004. In 2022, it introduced a Bachelor of Science in Pharmaceutical Sciences in collaboration with UM’s Faculty of Health Sciences, followed by a new Master’s in Pharmaceutical Administration in 2023. In recent years, SKL-QRCM has also signed dual-degree agreements with universities in mainland China, providing student exchange opportunities. Giving Back to the Community SKL-QRCM also provides a wide range of services to the Macao community. Since the Law on Pharmaceutical Activity in the Field of Traditional Chinese Medicine and the Registration of Traditional Chinese Medicines was enacted in 2021, several SKL-QRCM experts have been appointed to the Commission of Experts and Advisors for the Evaluation of Traditional Chinese Medicines, offering essential guidance on the registration and quality of Chinese medicine products and supporting decision-making of the Pharmaceutical Administration Bureau of Macao. SKL-QRCM also offers Continuing Professional Development courses on topics such as new drug development and evidence-based medicine, collaborates with the Health Bureau on a breast cancer risk assessment project, and hosts science activities for over 40,000 primary and secondary students. Advancing the Chinese Medicine Industry With Macao’s ‘big health’ industry growing steadily, centred on Chinese medicine R&D and manufacturing, Prof Chen Xin emphasises that SKL-QRCM will continue to innovate Chinese medicine while preserving its traditions. The laboratory will develop modern pharmaceutical preparations of traditional Chinese medicine, including classical prescriptions, promote scientific and technological innovation in the field, encourage the integration of traditional medicine with cutting-edge technologies, and enhance interdisciplinary research between biomaterials, artificial intelligence and synthetic biology. ‘Through in-depth research into the mechanisms of Chinese medicine, we are aiming for original breakthroughs in quality and safety control. This work supports the Chinese medicine industry both in Macao and across the country,’ he says. 首屆「澳門藥品監管科學國際論壇—中藥高質量發展：理論與實踐」於2024年10月在澳大舉行 The 1st ‘Macau International Forum on Pharmaceutical Regulatory Science—High-Quality Development of Chinese Medicine: Theory and Practice’ took place in UM in October 2024
RkJQdWJsaXNoZXIy NzM0NzM2